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Abstract 
Proximity among economic agents in spatial clusters fosters invention and innovation. An alternative perspective 
stresses interregional collaborative networks in which individuals and groups are embedded in wide-ranging webs of 
relationships. This article use spatial statistical approaches to explore the changing structures of collaborative 
systems in American biotechnology from 1979 to 2009. Both network and spatial patterns of association on 
American metropolitan areas over the two periods are explored. Results show that intermetropolitan network 
complexity has broadened and deepened. While inventors in major metropolitan areas are the foremost collaborators, 
a dense web of knowledge exchange has emerged that is not singularly controlled by a handful of intermediaries. 
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1. Introduction 
Regional differences of inventive activity and economic growth are important issues in economic geography. 
These differences are generally explained by the theory of localized knowledge spillovers (known as LKSs), which 
argues that geographical proximity of economic actors – inventors, firms, and research institutions – in clusters 
enhances interpersonal interaction and communication, labor mobility, and research collaboration. Empirical 
evidence for the presence of LKSs is widespread in cities and regions across the US and Europe. Spatial 
concentration of inventive firms in clusters enhances the possibility of knowledge exchange and lowers costs 
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through trade in goods and services, labor mobility, research collaboration, and interpersonal communication [1, 2, 3, 
4, 5]. 
While studies of LKSs and geographical proximity are prominent in the geography of invention and innovation, 
knowledge flows also occur in wide-ranging circulation, some scholars highlight the role of collaborative networks 
in which individuals and groups are embedded in webs of social relationships through formal connections and 
informal linkages [6, 7]. Breschi and Lissoni [8] argued that collaborative networks are channels for knowledge 
flows that are not limited to local boundaries but can span long distances. This is especially apparent in high-
technology industries such as biotechnology where research-collaboration through global networks has become 
crucial for inventive performance [9, 10, 11]. Combining both local and complementary non-local skills and 
competences are considered a major strategy for ‘firms evolving in a dynamic environment that requires rapid 
adaptation’ [6, p. 1151] and can curtail negative technological lock-in [12, 13]. Phrases such as ‘local sticky and 
global ubiquitous’ [12], ‘local buzz and global pipelines’ [14] stress global and local knowledge exchange within 
and between different regions. The space of knowledge flows is no longer tightly bundled within a given territorial 
boundary, but regarded as a kind of network-based system where knowledge flows circulate arounbd alignments of 
actors in different places [15].  Cities in such a spatially stretched economic sphere are immersed in global networks 
where knowledge collaboration and exchange are decisive forces for technological advance. 
The existence of collaborative networks raises a critical challenge for the investigation and understanding of the 
complex dynamic and network dimensions of externalities. The focal point here is to investigate the relative 
importance of spatial compared with network-based proximity on biotechnology co-invention in shaping the US 
urban structure of knowledge flows. An integrated methodology including both spatial and social network analyses 
are explicitly applied and compared. 
2. Knowledge, proximity, and network-based space 
Considerable research effort has been made to identify the nature and strength of LKSs by showing that higher 
rates of research and development, invention and innovation, entrepreneurial activity, and high-technology 
production are bounded in space [1, 2, 3, 4, 5]. Other studies increasingly stress that access to external knowledge is 
also critical to triggering successful innovation and regional development [10, 16]. Breschi and Malerba [17] argued 
that strong external links vital regional competitive advantages. Bathelt et al. [14] showed that dynamic firms in 
successful clusters by building and maintaining a variety of internal and external knowledge resources. In addition, 
advanced information and communication technologies reduce costs of moving knowledge and increase access and 
availability of universal resources [18]. The concepts of extra-local links and external knowledge resources provide 
new ways for explaining the geography of invention and innovation. Technological and commercial successes of 
many firms in Silicon Valley, for example, are closely tied to partners located in other regions and countries [19].  
Innovation and invention not only require local interaction between firms within a cluster, but they also need ties 
among distant actors that provide access to complementary information, skills, and technologies [10, 12, 13].  
Knowledge flows are no longer tightly bundled within a given territorial boundary. The relational pattern functions 
as a network-based system associated with different geographical sites.  Knowledge flows in that system are 
dependent upon shifting alignments of economic actors in different locations in pursuit of particular corporate goals 
[15]. Many ties between firms in Silicon Valley and Taiwan, for example, are shaped by interpersonal connections 
between Taiwanese nationals with educational and working experience in both places [19]. A framework of 
intermetropolitan co-invention networks is proposed here with an emphasis on American biotechnology for the 
following reasons. First, intense invention and innovation is particularly significant in biotechnology. A large 
portion of biotechnology value-chains (e.g., venture capital, basic research, R&D, human resources) occurs in few 
global cities such as Boston and San Francisco in North America, and Cambridge, Munich, and Stockholm in 
Europe [20]. Second, the global circulation of knowledge through extra-local links provides a diversity of 
knowledge exchange opportunities for local learning and invention. Individual cities link to and integrate with a 
global network-based system. Each city has a distinctive knowledge architecture that supports local clients and 
customers, but they also provide markets and economies of scale for firms whose activities span multiple distant 
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locations [10, 15]. Access to these systems is of particular importance for inventive biotechnology firms located in 
areas that are remote from the main research and market centers. Successful networking strategies assist in accessing 
external knowledge. Most remote firms crucially rely on non-local knowledge partners and global networking 
relationships [21]. 
I apply social network concepts to figure out intermetropolitan co-invention system of knowledge exchange. 
Knowledge is embedded in individuals who reside in cities [22]. Figure 1 links the interface between 
intermetropolitan and social networks and its knowledge circulation. The upper part of the figure shows a simple 
geographical space with cities A to F, while the lower part is its social network counterpart, as individual inventors 
are located in different cities. Links in the lower part are co-inventive activities. Some inventors have extra-local 
relationships with inventors located in other cities, while others only collaborate with local partners. Social relations 
underpin and facilitate interactions and communication that lead to co-patenting. These inventive-ties shape the 
intermetropolitan network shown in the upper part of Figure 1. City C is directly connected to A, D, and E, 
indirectly connected to B, and has no connection with F. Inventors in City F only co-invent with local partners. They 
are isolated from direct bonds with non-local inventors and it is assumed that they do not exchange knowledge with 
inventors in other cities.  
 
Fig. 1. Intermetropolitan network of co-invention and knowledge circulation. 
3. Methodology  
Each metropolitan area’s co-invention rate (or co-patenting rate, both terms are used interchangeably) is 
estimated by dividing its annual co-patent count by its total number of wage and salary jobs. The ratio is multiplied 
by a scaling factor of 1,000. The data for wage and salary jobs were retrieved from the US Bureau of Economic 
Analysis [23]. The GeoDa 1.6 version for Windows generates the empirical estimates [24]. 
3.1. Global-level measure of dependence 
Moran’s I is used to detect global-level spatial and network-based dependencies in biotechnology co-invention 
across the American metropolitan areas. This statistic provides an overall measure of the strength of cross-sectional 
autocorrelation in a data distribution [25]. It is calculated by comparing the co-patenting rate of each metropolitan 
area and the co-patenting rates of its ‘spatial’ and ‘network-based’ neighbors. The global-level measure is defined as: 
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where m is the number of metropolitan areas; wij is an element of an m×m weights matrix; xi and xj are the 
biotechnology co-patenting rates in areas i and j, respectively; and x  is the average of all x values. The 
interpretation of Moran’ I statistic is similar to the Pearson’s correlation coefficient in that both values range 
between +1 to -1. When I > 0, the overall pattern indicates positive autocorrelation, meaning that areas with similar 
co-patenting rates, either high or low, are spatially (or network-based) located ‘near’ each other. When I < 0, on the 
other hand, it shows negative autocorrelation, meaning that areas with dissimilar co-patenting rates are located ‘near’ 
each other. When I = 0, the overall pattern is random, indicating that metropolitan biotechnology co-invention is 
independent of either spatial or network-based dependence. 
3.2. Local-level measure of dependence 
Local analysis is based on a local indicator of spatial association (also called LISA), which allows for the 
decomposition of Moran’s I into the contribution of each individual area. The Local Moran statistic provides a 
means to assess significance of local spatial patterns [26]. A map combining the information on the locations and the 
significance of Local Moran statistics is referred to as a LISA cluster map. Ó hUallacháin and Lee’s [27] approach is 
used to distinguish between the following possible local association patterns in both the spatial and network-based 
systems. 
 
1. Co-invention cores (high-high): These are metropolitan areas with high co-patenting rates and are similar to their 
neighbors. 
2. Co-invention peripheries (low-low): These are metropolitan areas with low co-patenting rates and are similar to 
their neighbors. 
3. High co-invention islands (high-low): These are metropolitan areas with high co-patenting rates but are 
significantly different from their neighbors.   
4. Low co-invention islands (low-high): These are metropolitan areas with low co-patenting rates but are 
significantly different from their neighbors.  
5. Non-significant areas: Based on a conditional permutation approach, these are metropolitan areas with non-
significant Local Moran statistics (p > 0.05), indicating a failure to reject the null hypothesis of spatial 
randomness. 
 
Two types of LISA cluster maps, spatial and network-based, are compared to identify significant cores, 
peripheries, and islands across metropolitan areas. If a co-inventive core (high-high) appears in the spatial LISA 
cluster map, it indicates that spatial dependence is important in biotechnology co-patenting. If the same neighboring 
areas constitute a co-inventive core in the network-based LISA cluster map, collaborative relationships are defined 
by both spatial and network-based associations. More than likely differences in spatial and network-based 
dependencies occur. In particular, network-based LISA cluster maps with significant no spatial dependence should 
show co-inventive cores that are geographically scattered. Collaborative networks often favor patenting by inventors 
living in geographically dispersed locations. Moreover, low co-inventive islands in the network-based system are 
probably common as few major biotechnology centers exist and most areas’ ties are restricted to a few major distant 
centers. 
To capture the neighboring structure of each observation, whether from the aspect of spatial or network-based 
proximity, needs a weights matrix W specifying the interaction strength between each pair of metropolitan areas. 
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Each row i of matrix W has elements wij corresponding to the columns j. Three principal spatial weight choices exist: 
contiguity (wij =1 for i and j sharing a common boundary); distance (wij =1 for dij < δ) where dij is the distance 
between areas i and j; or the number of nearest neighbors. Owing to the ‘island’ nature of US metropolitan areas and 
the wide variation in urban spacing, the number of nearest neighbors -- an area’s k value -- is perhaps the best spatial 
choice in identifying neighboring metropolitan areas in the continental US. Concern for the stability of the LISA 
cluster maps in the Monte Carlo simulations led to the selection of ten nearest neighbors or 7 percent of all possible 
metropolitan neighbors. This number of nearest neighbors defines discernible regional groupings using the smallest 
k value. 
The network-based weights matrix Wn is based on the annual number of times each pair of metropolitan areas is 
jointly involved in biotechnology co-patenting. For any two metropolitan areas, an intermetropolitan tie is 
established if inventors from both areas co-invent the same patent. The more often inventors from distinct areas co-
invent, the stronger are intermetropolitan relational ties. This network-based weights matrix Wn is obtained by 
converting the intermetropolitan network of biotechnology co-invention value matrix into a set of binary relations. 
The original value matrix is dichotomized using the average number of times that metropolitan areas are tied in 
biotechnology co-patenting [7]. When the frequency of two areas i and j participating in co-patenting is greater than 
or equal to an average-based cut-off point then wij =1, indicating that both areas are relationally connected as 
neighbors; otherwise wij = 0. In summary, an intermetropolitan system of biotechnology co-invention is constructed 
to obtain a network-based weights matrix. The simplest form of an intermetropolitan network consists of a square 
actor-by-actor matrix, where the rows and the columns represent the same set of metropolitan areas. The 
relationships between every possible pair of areas provide a way to assess the structure of connections within which 
these areas are embedded. In this analysis of 150 metropolitan areas, a 150×150 symmetrical matrix was generated 
for 1979 and 2009. The elements on the off-diagonal are the annual number of times each pair of metropolitan areas 
joining in biotechnology co-patenting. These elements indicate the nature and strength of interconnected ties that 
facilitate knowledge flows across urban boundaries. 
4. Data and observations 
Aspects of biotechnology knowledge exchange are encapsulated in patent co-invention, which occurs when a 
patent has more than one inventor [28, 29]. I follow Hall et al. [30], Cortright and Mayer [31], and Hevesi and 
Bleiwas [32] in using US patent classes 424, 435, 514, and 800 to define biotechnology. Classes 424 and 514 are 
drugs, particularly bio-affecting and body-treating compositions. Class 435 is a chemical grouping and includes 
molecular biology and microbiology inventions. Class 800 encompasses multicellular living organisms, unmodified 
parts thereof, and related processes [33]. Patents in these classes in 1979 were extracted from the National Bureau of 
Economic Research (NBER) databases [30]. The 2009 data were provided by the USPTO [33]. 
The geographical units in each year are the Metropolitan Statistical Areas (MSAs) defined in the intermediate 
year of 1999. This common definition identifies 275 areas composed of 258 metropolitan statistical areas and 17 
consolidated metropolitan statistical areas (CMSAs). Primary metropolitan statistical areas (PMSAs) are not 
considered separate cases. Owing to the uneven distribution of biotechnology patents across cities, small areas 
without any co-patented awards are discarded. This sidesteps swamping the analysis with cases that have no co-
patenting and the likelihood that they would be mistakenly identified as outliers. The number of observations is 
reduced to 150 large areas that had at least one biotechnology co-patent awarded in 1999. 
Patents generated by multiple are distinguished from those by solo inventors. Each patent must have at least one 
inventor located in one of the 150 large metropolitan areas. Foreign partners are ignored, which restricts the analysis 
to domestic aspects of the American urban system. I specify the geography of biotechnology co-patenting by 
attributing each co-patent to the metropolitan areas where the inventors reside. Co-patents with inventors living in 
multiple areas are allocated fractionally, which corresponds with Maggioni et al. [7] and Ejermo and Karlsson [28]. 
For example, if a co-patent with four co-inventors located in four different MSAs, one-quarter of the co-patent is 
allotted to each MSA. Some inventors have extra-local relationships with inventors in other areas, while others only 
collaborate with local partners. The latter are isolated from direct bonds with nonlocal inventors, and it is assumed in 
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this analysis that they do not exchange knowledge with inventors in other areas. The website of US Bureau of 
Economic Analysis provided the job numbers  [23]. 
Patenting in 351 biotechnology is large and growing—from 883 in 1979 to over 6,356 in 2009, as shown in Table 
1. Co-patenting increased faster—from 55 to 81% of biotechnology awards. Average team size increased from 2.54 
co-inventors in 1979 to 4.07 in 2009. Table 2 shows the geographical reach of biotechnology co-patenting across the 
150 large areas. Most co-patenting occurs within the same metropolitan area, but the trend reveals increasing 
interconnected collaboration—from 17 in 1979 to 38% in 2009. Moreover, a growing number of metropolitan areas 
jointly participated in co-patenting, leading to a wider network of collaboration. In 1979, co-patenting never 
stretched beyond three metropolitan areas, but by 2009, a handful of co-patents tied inventors of five and more areas. 
In short, knowledge collaboration in biotechnology advance is deepening and broadening across the city system.  
Table 1.  Number of Biotechnology Patents, 1979 and 2009 
 
 
*Co-Patenting Percentage = (co-patents/total patents)×100  
Sources: Hall et al. [29], US Patent and Trademark Office [32] 
 
Table 2.  Biotechnology co-patenting, percentage intra-metropolitan and intermetropolitan, 1979, 2009 
 1979 2009 
Intra-metropolitan (co-patenting in the same metropolitan area) 83.2 62.3 
Intermetropolitan (co-Patenting with a different metropolitan area)  16.8  37.7 
Co-patenting across two areas  16.3 30.0 
Co-patenting across three areas 0.5 6.7 
Co-patenting across four areas 0.0 0.8 
Co-patenting across five Areas (and above) 0.0 0.2 
Sources: Hall et al. [29], US Patent and Trademark Office [32] 
5. Results 
Table 3 shows Moran’s I results for metropolitan co-patenting rates using the ten nearest neighbors as spatial 
weights and the co-patenting frequencies as network-based weights, respectively. Only the 2009 network presents 
significant global dependence with a negative coefficient indicating that metropolitan areas with dissimilar co-
patenting rates are significantly network-based associated. This result is interpreted as evidence that biotechnology 
centers with low co-patenting rates are significantly dependent on ties to a major biotechnology center. This finding 
for 2009 alone suggests that a set of network-based dependencies are perhaps developing that link minor and major 
biotechnology centers. 
 
1979 2009 
Co-patents     484      5125 
Solo patents     399      1231 
Total patents     883      6356 
Co-patenting percentage*        54.81       80.63 
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Table 3 Moran’s I statistics for metropolitan co-patenting rates  
(type of weights matrix) 1979 2009 
10 nearest neighbors 0.0104 (0.224) 0.0247 (0.141) 
Average-based cut-off point = 1 0.0262 (0.131)  
Average-based cut-off point = 2   
Average-based cut-off point = 3  -0.0848 (0.015) 
Note: Numbers in parentheses are two-tailed significance levels. 
 
Figure 2 shows spatial LISA cluster maps of metropolitan co-invention using ten nearest neighbors as spatial 
weights in 1979 and 2009. In 1979, significant LISA clusters are largely absent. A co-invention core of metropolitan 
areas with high co-patenting rates occurs in the Midwest focused on Lafayette (Indiana), St. Louis (Missouri), St. 
Joseph (Missouri), and Des Moines (Iowa). This Midwest co-invention biotechnology focus is related to medical 
research, especially new technologies associated with bacteria. The core has several neighbors that are low co-
invention islands. These islands are Sioux City (Iowa), Omaha (Nebraska), Lincoln (Nebraska), Columbia 
(Missouri), Toledo (Ohio), and Dayton-Springfield (Ohio). An indeterminate co-invention periphery (low-low) 
occurs throughout the Intermountain West and the Southeast with focal points in Billings (Montana), Boise City 
(Idaho), Flagstaff (Arizona), Santa Fe (New Mexico), Lubbock (Texas), Dallas (Texas), Shreveport-Bossier 
(Louisiana), and Tallahassee (Florida). This region is inconsequential in American biotechnology co-patenting. 
However, in 2009, this co-invention periphery noticeably expanded stretching from east Texas to Alabama. A small 
co-invention core is evident in the Midwest around St Louis (Missouri), Iowa City (Iowa), and Rochester 
(Minnesota). 
Figure 3 depicts network but not spatial associations of metropolitan areas, which provides an alternative 
perspective on co-invention ties. The collaborative patterns of American biotechnology based on interconnected co-
patenting are mostly composed of low co-invention islands (low-high), and a few prominent co-invention cores 
(high-high). Over the course of the period 1979-2009, the latter steadily became more explicit and interpretation of 
the network-based system concentrates on the 2009 results. Major biotechnology centers that form the 2009 
network-based core include New York (NY), San Francisco (CA) , Washington-Baltimore (DC), Boston (MA), 
Denver (CO), Seattle (WA), and Raleigh-Durham (NC). Smaller areas are also focal points of this co-invention core 
including the university towns of Fort Collins (CO), Iowa City (IA), Lafayette (IN), Lansing (MI), Lexington (KY), 
Bryan-College Station (TX), and Bloomington-Normal (IL). Santa Fe (NM) with its large national laboratory, 
Rochester (MN) with a large medical clinic, and New London (CT) that has a cluster of pharmaceutical companies 
belong to the 2009 core. These areas have high co-patenting rates and their closely network-based associates have 
high co-patenting rates. These associations suggest that a small number of major biotechnology centers dominate the 
network-based system. Inventors that co-invent in the minor centers are tied to inventors in the major centers and 
not to inventors in other minor areas. 
A comparison of the spatial and network-based LISA cluster maps especially in 2009, suggests that the latter 
better define co-patenting relationships. The 2009 spatial LISA cluster map did not identify any striking spatial 
associations. A small co-invention core occurs in the Midwest, a periphery is evident from East Texas to Alabama, 
and San Francisco and San Diego are high co-invention islands. The 2009 network-based LISA cluster map 
identifies the biotechnology co-invention cores and remaining areas that are far less engaged in co-patenting. 
However, inspection of co-patenting ties of some of the major co-invention centers show that their network-based 
associations have regional biases. San Francisco and New York dominate the network-based co-invention core. 
Their co-invention collaboration spans more than 70 other metropolitan areas across the US. San Francisco’s 
strongest partners are San Diego, Los Angeles, New York, Boston, Philadelphia, and Washington-Baltimore, so its 
ties are truly national. In contrast, New York’s strongest partners are mainly eastern including Boston, New Haven, 
Hartford, Philadelphia, and Washington-Baltimore. New York is also strongly tied to San Francisco, but its links 
with Los Angeles and San Diego are weaker. A third example illustrates the role of regional effects. Seattle’s 
collaborations span 40 metropolitan areas but its strongest links are with San Francisco, Los Angeles, and San Diego. 
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These results suggest that the co-patenting relationships of major biotechnology centers are national and regional but 
not spatial. Nearest neighbor associations are far less important compared with both network-based and regional 
relationships. 
Note: Nearest neighbor k=10. 
Fig. 2. Spatial LISA cluster map of metropolitan co-invention in 1979 and 2009 
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Note: Average based cut-off point in 1979=1; in 2009=3. 
Fig. 3. Network-based LISA cluster map of metropolitan co-invention in 1979 and 2009 
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6. Conclusions 
Co-patenting patterns offer glimpses into networks of collaborative knowledge exchange within and between 
cities. Theories of localized knowledge spillovers emphasize that geographical concentration of inventive firms, 
research institutions, and creative individuals. Knowledge transfer is bounded in space because human interaction 
relies on face-to-face exchange of tacit information. Other scholars stress the role of collaborative networks in 
which individuals and groups are embedded in wide ranging webs of direct and indirect relationships that span long 
distances. Corporate technological and commercial success in geographical clusters is embedded in larger network 
structures where close ties to nonlocal knowledge partners are essential. In order to understand the changing 
structures of urban collaborative networks, I exploited biotechnology co-patenting datasets that detail key 
relationships linking US metropolitan areas and compare properties of these systems in 1979 and 2009. Theoretical 
city systems provide a context for the analysis, and the results are comparable with previous investigations of 
intercity links. 
This research investigates the explanatory roles of spatial and network-based systems in biotechnology 
information flows. Biotechnology co-invention across 150 American metropolitan areas in 1979 and 2009 is 
examined. Moran’s I global test of dependence mostly reveals randomness in both systems. Only the 2009 network-
based system turned out to be significant. The coefficient is negative and interpreted as evidence that areas with 
little co-patenting tend to collaborate with major biotechnology centers. Analysis of local dependence using LISA 
cluster maps shows few discernable spatial patterns, but the network-based LISA cluster maps highlighted the 
major co-patenting centers. Minor centers turned out to be significantly dependent on the major centers for 
invention collaboration. Accordingly, biotechnology co-invention dependence is not spatial, but evidence of some 
regional effects is noted.  
The development of network-based co-invention from 1979 to 2009 reveals that a growing number of urban 
areas jointly participated in co-patenting as major co-invention centers with significant ties to each other. By 2009, 
more areas were interconnected and knowledge flows were less likely to be locally bounded and substantial 
collaboration and exchange occur between distant partners. This result suggests that Cooke’s (2006) emphasis on 
the highest-ranking biotechnology centers overlooks important changes occurring at lower levels. Regional 
knowledge flows remain robust as New York, for example, has collaborative links with many biotechnology centers 
across the country, its strongest ties are still on the Eastern Seaboard. In contrast, San Francisco’s non-local partners 
are essential as its co-inventive ties are clearly national in scope, but Los Angeles and San Diego are favored 
partners. Seattle’s ties also span the country, but its co-inventors tend to collaborate more with partners located in 
the major Pacific Coast centers.  
In this article, I tracked co-patenting links in the networks to account for bilateral knowledge flows between 
metropolitan areas, but the directionality of connections was disregarded. Future research should attempt to 
distinguish between the incoming and outgoing knowledge flows of each node in the system. I also ignored network 
connections between American cities. Analysis of global collaboration in biotechnology is clearly needed both to 
understand the changing properties of the network and the functions of major biotechnology centers. This analysis 
is extendable to knowledge flows in other technologies. Comparison of biotechnology with, for example, 
semiconductor, computer, chemical, or mechanical urban systems of technological advance is feasible. 
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